InMed Pharmaceuticals Inc [NASDAQ: INM] gained 109629487% or 1329997.55 points to close at $1330000.0 with a heavy trading volume of 109629487 shares.
It opened the trading session at $4.2, the shares rose to $5.5 and dropped to $3.36, the range by which the price of stock traded the whole day. The daily chart for INM points out that the company has recorded -11.03% loss over the past six months.
If we look at the average trading volume of 1.33M shares, INM reached to a volume of 109629487 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about InMed Pharmaceuticals Inc [INM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INM shares is $400.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INM stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 0.67, with the Price to Cash per share for the same quarter was set at 3.91.
Trading performance analysis for INM stock
InMed Pharmaceuticals Inc [INM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 63.29. With this latest performance, INM shares gained by 40.73% in over the last four-week period, additionally sinking by -11.03% over the last 6 months – not to mention a drop of -18.35% in the past year of trading.
InMed Pharmaceuticals Inc [INM]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and InMed Pharmaceuticals Inc [INM] shares currently have an operating margin of -169.65% and a Gross Margin at 15.75%. InMed Pharmaceuticals Inc’s Net Margin is presently recorded at -168.90%.
Return on Equity for this stock declined to -73.43%, with Return on Assets sitting at -73.43%.
An analysis of Institutional ownership at InMed Pharmaceuticals Inc [INM]
There are presently around $10.18%, or 10.33% of INM stock, in the hands of institutional investors. The top three institutional holders of INM stocks are: SABBY MANAGEMENT, LLC with ownership of 0.31 million shares, which is approximately 3.1961%. VIRTU FINANCIAL LLC, holding 86684.0 shares of the stock with an approximate value of $$23000.0 in INM stocks shares; and VIRTU FINANCIAL LLC, currently with $$4731.0 in INM stock with ownership which is approximately 0.1854%.
